Sat 26 December 2020:
COVID-19 vaccines developed by BioNTech and Pfizer have been delivered to all the EU countries that will begin vaccination on Sunday, the EU Commission president announced on Saturday.
The Dec. 27 start date – confirmed by EU Commission chief Ursula von der Leyen, Austria, Germany and Italy – will be almost three weeks after the world’s first fully tested COVID-19 vaccination was administered in England.
“In Germany we will start, if the approval comes as planned, on Dec. 27. The other countries in the EU want to be able to start and want to start from Dec. 27,” Health Minister Jens Spahn said before an online meeting with Chancellor Angela Merkel and executives from vaccine maker BioNTech.
Italy said it would start vaccinating health workers on Dec. 27. Vaccinations will also start in Austria on that date, Chancellor Sebastian Kurz said on Twitter.
Student medics, retired doctors, pharmacists and soldiers are being drafted into a European COVID-19 vaccination campaign of unprecedented scale.
However, the Dutch took a different tack, opting to wait until Jan. 8 to launch their vaccination programme, citing the need for trust in the process.
Announcing the delivery of vaccines in a video message, EU Commission President Ursula von der Leyen said: “We are starting to turn a new page in a difficult year. Deliveries have been made, and tomorrow health officials across Europe will start vaccination.”
Today, we start turning the page on a difficult year. The #COVID19 vaccine has been delivered to all EU countries.
Vaccination will begin tomorrow across the EU.
The #EUvaccinationdays are a touching moment of unity. Vaccination is the lasting way out of the pandemic. pic.twitter.com/pYOj5vS2gV
— Ursula von der Leyen (@vonderleyen) December 26, 2020
Von der Leyen said that all EU countries have access to the vaccine at the same time, and more vaccines will arrive soon, by which people can gradually return to normal life.
The BioNTech/Pfizer vaccine was the first that got approval from the European Medicines Agency (EMA), the EU’s medicines regulator.
The EMA is currently assessing the vaccine from American drug maker Moderna and is expected to make a decision on the vaccine in the first week of January.
The EU Commission has neither disclosed how many doses of the vaccine have been distributed to member states so far, nor confirmed how many vaccines have been sent to which country.
But for now, the number of doses is quite small due to limited production.
The EU Commission, on behalf of all member states, has so far signed contracts with six companies to purchase a total of two billion doses of vaccines.
The Union will receive 400 million doses of the vaccine from AstraZeneca, 300 million from Sanofi-GSK, 400 million from Johnson and Johnson, 300 million from Pfizer and BioNTech, 405 million from CureVac and 160 million from Moderna.
Novavax has also reached the contract stage for 200 million doses. With the signing of this agreement, the number of doses the EU can take will reach 2.2 billion.
Each EU country will determine who will be given priority, and there is no common EU decision or recommendation on this issue.
The COVID-19 pandemic has claimed more than 1.75 million lives in 191 countries and regions since last December.
Over 79.92 million cases have been reported worldwide, with more than 45.08 million recoveries, according to figures compiled by the US Johns Hopkins University.
The US, India, and Brazil remain the worst-hit countries in terms of the number of cases.
While new restrictions are imposed ahead of the holiday season, especially across Europe, countries are approving and procuring vaccines to end the pandemic.
FOLLOW INDEPENDENT PRESS:
TWITTER (CLICK HERE)
https://twitter.com/IpIndependent
FACEBOOK (CLICK HERE)
https://web.facebook.com/ipindependent
Think your friends would be interested? Share this story!